12-hour Versus 24-hour Postpartum Magnesium Sulphate for Preeclamptic Patients
Status:
Not yet recruiting
Trial end date:
2022-01-01
Target enrollment:
Participant gender:
Summary
To compare the use of magnesium sulfate for 12 hours versus 24 hours in postpartum women with
pre-eclampsia with severe features , to ensure maximum efficacy of anticonvulsant action that
can be achieved with least exposure to Mgso4 side effects.